India · English
Centre Caps Cancer Drug Trade Margins At 30 Per Cent, Supreme Court Questions High Prices Of Other Medicines
New Delhi, October 12, 2026: The Central government informed the Supreme Court on Monday, October 12, that it has capped trade margins on anti-cancer drugs at 30% of the maximum retail price (MRP). The move comes weeks after the top court raised serious concerns over the steep prices of cancer medicines and the profits made on their sale. However, a Bench of Justices Vikram Nath and Sandeep…
Read the full report at Free Press Journal →
How 2 newsrooms ran it
2 of our sources carried this story over 0.3 hours. Free Press Journal filed first, at 17:38 IST. The headlines below are each outlet's own wording, in the order they published.
| Time IST | Outlet | Their headline |
|---|---|---|
| 17:38 | Free Press Journal | Centre Caps Cancer Drug Trade Margins At 30 Per Cent, Supreme Court Questions High Prices Of Other Medicines |
| 17:55 | Livemint | 'Why only cancer drugs?': SC questions Centre on trade margin cap, seeks wider price regulation |
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.